Back

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Alberto Foa'

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail
Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study
Doctor P. Yang (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes
Doctor S. Cuddy (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy
Doctor Y. Azumi (Kobe, JP)
Abstract
Presentation thumbnail
Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.
Doctor A. Lebreiro (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation in hypertrophic cardiomyopathy: clinical implications of an early detection through implanted cardioverter defibrillator
Doctor R. Morgagni (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources